Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus
- PMID: 1988952
- PMCID: PMC50847
- DOI: 10.1073/pnas.88.2.542
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus
Abstract
Sustained high titers of neutralizing antibodies were elicited in three chimpanzees after sequential injections of different human immunodeficiency virus 1 (HIV-1) antigen preparations derived from the HIV-1 BRU strain that included whole inactivated virus or purified recombinant proteins and then synthetic peptides identical to the major HIV-1 neutralizing epitope V3. The animals were challenged i.v. with 40 chimpanzee infectious doses (equivalent to 100 tissue culture 50% infectious doses) of a stock of HIV-1 IIIB isolate. After 6 mo of follow-up, all three animals appeared uninfected by serologic and virologic criteria, including polymerase chain reaction analysis and failure to isolate virus from peripheral blood lymphocytes, bone marrow, and lymph node tissue. Of two chimpanzees monitored for 1 yr, virus was isolated initially from one animal at 32 weeks, but the second chimpanzee was virus negative by all assays through 12 mo; the third animal has remained virus negative through 9 mo of follow-up. These results indicate that it is possible to elicit protection against, or significantly delay infection of, HIV-1 by immunization, thus laying the foundation for development of an HIV-1 vaccine.
Similar articles
-
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.J Infect Dis. 1996 Jan;173(1):52-9. doi: 10.1093/infdis/173.1.52. J Infect Dis. 1996. PMID: 8537682
-
Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.AIDS. 1991 Feb;5(2):169-76. doi: 10.1097/00002030-199102000-00006. AIDS. 1991. PMID: 2031689
-
Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.J Virol. 1989 Dec;63(12):5046-53. doi: 10.1128/JVI.63.12.5046-5053.1989. J Virol. 1989. PMID: 2555541 Free PMC article.
-
Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.AIDS Res Hum Retroviruses. 1991 Oct;7(10):813-23. doi: 10.1089/aid.1991.7.813. AIDS Res Hum Retroviruses. 1991. PMID: 1720628
-
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.J Virol. 1990 Aug;64(8):3779-91. doi: 10.1128/JVI.64.8.3779-3791.1990. J Virol. 1990. PMID: 2370681 Free PMC article.
Cited by
-
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2175-9. doi: 10.1073/pnas.89.6.2175. Proc Natl Acad Sci U S A. 1992. PMID: 1549578 Free PMC article.
-
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.PLoS Pathog. 2021 Nov 29;17(11):e1010016. doi: 10.1371/journal.ppat.1010016. eCollection 2021 Nov. PLoS Pathog. 2021. PMID: 34843602 Free PMC article.
-
Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain.J Virol. 1995 Apr;69(4):2271-8. doi: 10.1128/JVI.69.4.2271-2278.1995. J Virol. 1995. PMID: 7533854 Free PMC article.
-
DNA gene vaccination for HIV.Springer Semin Immunopathol. 1997;19(2):175-94. doi: 10.1007/BF00870267. Springer Semin Immunopathol. 1997. PMID: 9406345 Review. No abstract available.
-
Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.J Virol. 1998 Mar;72(3):2406-15. doi: 10.1128/JVI.72.3.2406-2415.1998. J Virol. 1998. PMID: 9499101 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical